Publications by authors named "Alan Wayne"

Claim this Profile
P
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies.
Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude, Deepa Bhojwani, Alan S Wayne

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL.
Colleen Annesley, Kristy Seidel, Qian Wu, Corinne Summers, Alan S Wayne

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL.
Colleen Annesley, Adam Lamble, Corinne Summers, Michael A Pulsipher, Alan S Wayne

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial.
Nirali N Shah, Eric S Schafer, Yueh-Yun Chi, Jemily Malvar, Kenneth M Heym, Alan S Wayne

Pediatr Blood Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemia.
Ravi Bansal, Deepa Bhojwani, Bernice F Sun, Siddhant Sawardekar, Alan S Wayne

Pediatr Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells.
Samy Jambon, Jianping Sun, Shawn Barman, Sakunthala Muthugounder, Xue Rachel Bito, Alan S Wayne

Blood Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium.
Eric S Schafer, Teresa Rushing, Kristine R Crews, Colleen Annesley, Susan I Colace, Alan S Wayne

J Natl Cancer Inst· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial.
Armin Ghobadi, Ibrahim Aldoss, Shannon Maude, Deepa Bhojwani, Alan Wayne

Res Sq· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing pediatric access to cell and gene therapies.
Crystal L Mackall, Catherine M Bollard, Nancy Goodman, Casey Carr, Rebecca Gardner, Alan S Wayne

Nat Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.
Anupam Verma, Yueh-Yun Chi, Jemily Malvar, Adam Lamble, Sonali Chaudhury, Alan S Wayne

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.
Alan S Wayne, Van Huynh, Nobuko Hijiya, Rayne H Rouce, Patrick A Brown

Haematologica· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Sarah K Tasian, Lewis B Silverman, James A Whitlock, Richard Sposto, Joseph P Loftus, Alan S Wayne

Haematologica· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium.
Eric S Schafer, Karen Chao, Alexandra M Stevens, Eunji Jo, Susan G Hilsenbeck, Alan S Wayne

Pediatr Blood Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects.
Francesco Ceppi, Ashley L Wilson, Colleen Annesley, Gabriella R Kimmerly, Corinne Summers, Alan S Wayne

Cancer Immunol Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
Lauren Pommert, Eric S Schafer, Jemily Malvar, Nathan Gossai, Ellynore Florendo, Alan Wayne

Am J Hematol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor.
Fan Fei, Liang Rong, Nan Jiang, Alan S Wayne, Jianming Xie

Mol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia.
Yongsheng Ruan, Hye Na Kim, Heather A Ogana, Eun Ji Gang, Shuangyue Li, Alan S Wayne

Exp Ther Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing therapy-associated neurotoxicity in children with ALL.
Deepa Bhojwani, Ravi Bansal, Alan S Wayne

Hematology Am Soc Hematol Educ Program· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of CAR T cells in cancer therapy.
Dimitrios L Wagner, Enrico Fritsche, Michael A Pulsipher, Nabil Ahmed, Mohamad Hamieh, Alan S Wayne

Nat Rev Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
Muna Qayed, Kwang Woo Ahn, Carrie L Kitko, Mariam H Johnson, Nirali N Shah, Alan Wayne

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.
Nirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, Deepa Bhojwani, Terry J Fry, Alan S Wayne

Pediatr Blood Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Eun Ji Gang, Hye Na Kim, Yao-Te Hsieh, Yongsheng Ruan, Heather A Ogana, Alan S Wayne, Elizabeth Wayner

Blood· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study.
Michael J Burke, Rumen Kostadinov, Richard Sposto, Lia Gore, Shannon M Kelley, Alan S Wayne

Clin Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvement.
Haneen Shalabi, Constance M Yuan, Amita Kulshreshtha, Alina Dulau-Florea, Dalia Salem, Alan S Wayne

Pediatr Blood Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-cell product performance in haematological malignancies before and after marketing authorisation.
Magdi Elsallab, Bruce L Levine, Alan S Wayne, Mohamed Abou-El-Enein

Lancet Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis